CL

Business profile & competitive position

Colgate-Palmolive Company (CL) is a Consumer Defensive name in the Household & Personal Products industry. It operates through two reportable segments: Oral, Personal and Home Care, and Hill’s Pet Nutrition. The first segment includes toothpaste, toothbrushes, soaps, deodorants, skin-health products, household cleaners and fabric conditioners; Hill’s produces specialty dog and cat foods. The company markets these products in more than 200 countries and territories through retailers, wholesalers, eCommerce platforms, veterinarians and certain direct-to-consumer channels.

In 2025, Oral Care accounted for 44% of worldwide net sales, Personal Care for 17%, Home Care for 16% and Pet Nutrition for 23%. That mix means the majority of revenue comes from frequently replenished, low-ticket staples rather than discretionary purchases. A business built on branded oral-care, personal-care and home-care products usually competes on brand recognition, shelf placement, distribution reach and price positioning against private-label alternatives. The 2025 revenue split also exposes Colgate-Palmolive to two different demand cycles: human household products and premium pet nutrition.

The margin and return data provide a nuanced view of competitive strength. The trailing net margin is 9.6%, while reported return on equity is 1,135.8%. An ROE figure of that magnitude generally does not come from operating returns alone; it usually signals a small or negative book-equity base magnified by leverage and share repurchases. Investors should read the 9.6% net margin as the operating profitability signal and treat the 1,135.8% ROE as more of a capital-structure artifact than standalone proof of a wide-moat return.

Financial posture

At a market capitalization of roughly $77.7 billion and a P/E multiple of 37.9, Colgate-Palmolive is priced at a clear premium to the broader market and to many other staples peers. That valuation implies the market is paying for stability, global brand strength and consistent cash generation rather than rapid top-line expansion. The 9.6% net margin supports a profitable, cash-generative business, but it does not fully explain the 37.9x multiple on its own.

The stock’s beta of 0.32 is consistent with the Consumer Defensive classification: the share price has historically moved a fraction of the broader market’s swings, reflecting recession-resistant demand for toothpaste, soap and pet food. Meanwhile, the 1,135.8% ROE is a reminder that accounting return on equity has been amplified by a leveraged capital structure. A forward-looking review typically combines this with interest coverage, debt maturities and free-cash-flow conversion to assess whether the balance sheet is being used efficiently or aggressively.

Strategic priorities & outlook

Colgate-Palmolive’s most recent 10-K outlines four operational priorities. The first is to drive organic sales growth and deliver consistent, compounded earnings-per-share growth. The second is to achieve operational efficiencies while growing free cash flow and using the balance sheet efficiently. The third is to leverage global brand reach, science-based innovation, an agile supply chain and best-in-class omni-channel demand generation. The fourth is to build capabilities in data, analytics and artificial intelligence and to evolve what the company calls a high-impact, inclusive culture.

Operationally, the filing notes that Walmart and its affiliates represented approximately 11% of 2025 net sales, and no other customer exceeded 10%. As of December 31, 2025, Colgate-Palmolive employed approximately 33,600 people across more than 100 countries, with over 84% located outside the United States. These facts reinforce that CL is a global distribution story, not a U.S.-centric one, and that a single retail relationship, while not dominant, is large enough to matter in any sales-volatility analysis.

Macro & geopolitical exposure

As a Household & Personal Products company, Colgate-Palmolive sits in a sector where macro exposure is less about recession-driven demand collapse and more about input-cost pressure, currency translation and trade policy. Key raw materials include surfactants, oils, chemicals, packaging resins and pulp, all of which are linked to commodity-price and energy-price cycles. Logistics and freight costs also flow through the income statement with meaningful sensitivity.

Because over 84% of employees are outside the U.S. and the company operates in more than 200 countries and territories, currency translation is a persistent factor in reported revenue and earnings. Tariffs, import quotas and local regulatory changes can alter manufacturing economics or shelf-price competitiveness. Pet-food operations add exposure to agricultural commodity inputs, veterinarian-channel dynamics and animal-health regulation. Consumer staples also face ongoing regulatory scrutiny around ingredients, labeling, sustainability claims and plastics usage, any of which can force formula or packaging changes.

Recent developments

Headlines around the stock in recent days have been generally positive and investor-focused. On November 2, 2026, BusinessWire reported that the Colgate Women’s Games launched its 51st season, highlighting a long-running corporate sponsorship. The same day, Benzinga noted that Colgate-Palmolive analysts lifted their forecasts after upbeat Q3 earnings. On November 1, 2026, The Motley Fool ran a side-by-side comparison of Colgate-Palmolive and Lululemon Athletica as consumer goods candidates for 2026, and on October 31, 2026, Fool published “3 Key Takeaways for Long-Term Investors” focused on CL. These articles do not constitute investment recommendations, but they illustrate that recent earnings performance has drawn attention from both sell-side forecasters and financial media.

Earnings behavior & post-earnings drift

Over the last eight reported quarters, Colgate-Palmolive has beaten consensus EPS estimates every time, for a 100% beat rate. The average earnings surprise across those quarters is 3.6%, which is positive but not outsized relative to some higher-beta names. The stock’s average 5-day price move after earnings over the same period is +2.35%, classified as an “up” drift.

The most recent four quarters tell a more detailed story. On October 30, 2026, CL reported EPS of $0.97 versus a $0.926 estimate, a 4.8% beat; the stock rose 2.25% the next day and was flat over the following five days. On July 31, 2026, EPS came in at $0.99 against a $0.947 estimate, a 4.5% beat; the next-day reaction was -1.56%, but the five-day drift was +2.16%. On May 1, 2026, EPS of $0.97 beat the $0.943 estimate by 2.9%; the stock fell 2.17% the next day yet drifted up 0.33% over the following week. On January 30, 2026, EPS of $0.95 beat a $0.912 estimate by 4.2%, producing a 1.77% next-day gain and a stronger +4.56% five-day drift.

The pattern suggests that short-term headline reactions are not the only source of post-earnings edge; the five-day drift has been positive on average even when one-day reactions were negative. The next scheduled report is January 29, 2027 before the market opens, with a consensus EPS estimate of $0.97. As of the October 30, 2026 snapshot, the current price was $97.43, RSI stood at 66.2 and the 50-day EMA was $90.87—meaning the stock was trading above its near-term moving average with momentum near overbought territory.

For a more complete picture of how institutional analysts currently view Colgate-Palmolive—including aggregate ratings, forward estimates and the latest consensus outlook—readers should consult the full institutional verdict page before forming any investment opinion.